O	O	0	12	Constitutive	Constitutive	B-NP	JJ	O	2	NMOD	O
O	O	13	23	expression	expression	I-NP	NN	O	11	SUB	O
O	O	24	26	of	of	B-PP	IN	O	2	NMOD	O
T1	B-Protein	27	30	p50	p50	B-NP	NN	B-protein	5	NMOD	B-protein
T14	B-Entity	31	40	homodimer	homodimer	I-NP	NN	I-protein	3	PMOD	I-protein
O	O	41	43	in	in	B-PP	IN	O	2	NMOD	O
O	O	44	51	freshly	freshly	B-NP	RB	B-cell_type	10	NMOD	B-cell_type
O	O	52	60	isolated	isolate	I-NP	VBN	I-cell_type	10	NMOD	I-cell_type
O	O	61	66	human	human	I-NP	JJ	I-cell_type	10	NMOD	I-cell_type
O	O	67	76	monocytes	monocyte	I-NP	NNS	I-cell_type	6	PMOD	I-cell_type
O	O	77	86	decreases	decrease	B-VP	VBZ	O	0	ROOT	O
O	O	87	91	with	with	B-PP	IN	O	11	VMOD	O
O	O	92	94	in	in	B-ADVP	FW	O	14	AMOD	O
O	O	95	100	vitro	vitro	I-ADVP	FW	O	18	NMOD	O
O	O	101	104	and	and	O	CC	O	18	NMOD	O
O	O	105	107	in	in	B-NP	FW	O	17	AMOD	O
O	O	108	112	vivo	vivo	I-NP	FW	O	18	NMOD	O
O	O	113	128	differentiation	differentiation	I-NP	NN	O	12	PMOD	O
O	O	128	129	:	:	O	:	O	11	P	O
O	O	130	131	a	a	B-NP	DT	O	22	NMOD	O
O	O	132	140	possible	possible	I-NP	JJ	O	22	NMOD	O
O	O	141	150	mechanism	mechanism	I-NP	NN	O	11	VMOD	O
O	O	151	162	influencing	influence	B-VP	VBG	O	22	NMOD	O
O	O	163	168	human	human	B-NP	JJ	O	27	NMOD	O
O	O	169	185	immunodeficiency	immunodeficiency	I-NP	NN	O	27	NMOD	O
O	O	186	191	virus	virus	I-NP	NN	O	27	NMOD	O
O	O	192	203	replication	replication	I-NP	NN	O	23	OBJ	O
O	O	204	206	in	in	B-PP	IN	O	27	NMOD	O
O	O	207	216	monocytes	monocyte	B-NP	NNS	B-cell_type	32	NMOD	B-cell_type
O	O	217	220	and	and	O	CC	O	32	NMOD	O
O	O	221	227	mature	mature	B-NP	JJ	B-cell_type	32	NMOD	B-cell_type
O	O	228	239	macrophages	macrophage	I-NP	NNS	I-cell_type	28	PMOD	I-cell_type
O	O	239	240	.	.	O	.	O	11	P	O

O	O	242	247	Human	Human	B-NP	JJ	O	4	NMOD	O
O	O	248	264	immunodeficiency	immunodeficiency	I-NP	NN	O	4	NMOD	O
O	O	265	270	virus	virus	I-NP	NN	O	4	NMOD	O
O	O	271	275	type	type	I-NP	NN	O	11	SUB	O
O	O	276	277	1	1	I-NP	CD	O	4	NMOD	O
O	O	278	279	(	(	O	(	O	10	DEP	O
O	O	279	282	HIV	HIV	B-NP	NN	O	9	NMOD	O
O	O	282	283	-	-	B-NP	HYPH	O	9	P	O
O	O	283	284	1	1	I-NP	CD	O	10	DEP	O
O	O	284	285	)	)	O	)	O	4	NMOD	O
O	O	286	296	replicates	replicate	B-VP	VBZ	O	0	ROOT	O
O	O	297	301	more	more	B-ADVP	RBR	O	13	AMOD	O
O	O	302	313	efficiently	efficiently	I-ADVP	RB	O	11	VMOD	O
O	O	314	316	in	in	B-ADVP	FW	O	13	AMOD	O
O	O	317	322	vitro	vitro	I-ADVP	FW	O	14	AMOD	O
O	O	323	325	in	in	B-PP	IN	O	13	AMOD	O
O	O	326	340	differentiated	differentiate	B-NP	VBN	B-cell_type	18	NMOD	B-cell_type
O	O	341	352	macrophages	macrophage	I-NP	NNS	I-cell_type	16	PMOD	I-cell_type
O	O	353	357	than	than	B-PP	IN	O	13	AMOD	O
O	O	358	360	in	in	B-PP	IN	O	19	PMOD	O
O	O	361	368	freshly	freshly	B-NP	RB	B-cell_type	23	NMOD	B-cell_type
O	O	369	377	isolated	isolate	I-NP	VBN	I-cell_type	23	NMOD	I-cell_type
O	O	378	387	monocytes	monocyte	I-NP	NNS	I-cell_type	20	PMOD	I-cell_type
O	O	387	388	.	.	O	.	O	11	P	O

O	O	389	391	We	We	B-NP	PRP	O	2	SUB	O
O	O	392	404	investigated	investigate	B-VP	VBD	O	0	ROOT	O
O	O	405	412	whether	whether	B-SBAR	IN	O	2	VMOD	O
O	O	413	417	this	this	B-NP	DT	O	5	SUB	O
O	O	418	421	may	may	B-VP	MD	O	3	SBAR	O
O	O	422	424	be	be	I-VP	VB	O	5	VC	O
O	O	425	431	partly	partly	I-VP	RB	O	6	VMOD	O
O	O	432	441	explained	explain	I-VP	VBN	O	6	VC	O
O	O	442	444	by	by	B-PP	IN	O	8	VMOD	O
O	O	445	452	changes	change	B-NP	NNS	O	9	PMOD	O
O	O	453	455	in	in	B-PP	IN	O	10	NMOD	O
O	O	456	466	expression	expression	B-NP	NN	O	11	PMOD	O
O	O	467	469	of	of	B-PP	IN	O	12	NMOD	O
T15	B-Entity	470	472	NF	NF	B-NP	NN	B-protein	16	NMOD	B-protein
T15	I-Entity	472	473	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
T15	I-Entity	473	479	kappaB	kappaB	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	480	484	with	with	B-PP	IN	O	12	NMOD	O
O	O	485	493	monocyte	monocyte	B-NP	NN	O	19	NMOD	O
O	O	494	509	differentiation	differentiation	I-NP	NN	O	17	PMOD	O
O	O	509	510	.	.	O	.	O	2	P	O

O	O	511	513	We	We	B-NP	PRP	O	2	SUB	O
O	O	514	526	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	527	531	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	532	544	constitutive	constitutive	B-NP	JJ	O	5	NMOD	O
O	O	545	555	expression	expression	I-NP	NN	O	14	SUB	O
O	O	556	558	of	of	B-PP	IN	O	5	NMOD	O
T16	B-Entity	559	561	NF	NF	B-NP	NN	B-protein	9	NMOD	B-protein
T16	I-Entity	561	562	-	-	O	HYPH	I-protein	9	NMOD	I-protein
T16	I-Entity	562	568	kappaB	kappaB	B-NP	NN	I-protein	6	PMOD	I-protein
O	O	569	571	in	in	B-PP	IN	O	5	NMOD	O
O	O	572	579	primary	primary	B-NP	JJ	B-cell_type	13	NMOD	B-cell_type
O	O	580	585	human	human	I-NP	JJ	I-cell_type	13	NMOD	I-cell_type
O	O	586	595	monocytes	monocyte	I-NP	NNS	I-cell_type	10	PMOD	I-cell_type
O	O	596	603	changed	change	B-VP	VBD	O	3	SBAR	O
O	O	604	617	significantly	significantly	B-ADVP	RB	O	14	VMOD	O
O	O	618	622	with	with	B-PP	IN	O	14	VMOD	O
O	O	623	638	differentiation	differentiation	B-NP	NN	O	16	PMOD	O
O	O	639	641	in	in	B-ADVP	FW	O	14	VMOD	O
O	O	642	647	vitro	vitro	I-ADVP	FW	O	18	AMOD	O
O	O	648	650	to	to	B-PP	TO	O	18	PMOD	O
O	O	651	659	monocyte	monocyte	B-NP	NN	B-cell_type	24	NMOD	B-cell_type
O	O	659	660	-	-	O	HYPH	O	24	NMOD	O
O	O	660	667	derived	derive	B-NP	VBN	O	24	NMOD	O
O	O	668	679	macrophages	macrophage	I-NP	NNS	B-cell_type	29	NMOD	B-cell_type
O	O	680	681	(	(	O	(	O	27	DEP	O
O	O	681	685	MDMs	MDM	B-NP	NNS	B-cell_type	27	DEP	B-cell_type
O	O	685	686	)	)	O	)	O	24	NMOD	O
O	O	687	690	and	and	O	CC	O	29	NMOD	O
O	O	691	706	differentiation	differentiation	B-NP	NN	O	18	PMOD	O
O	O	707	709	in	in	B-ADVP	FW	O	31	AMOD	O
O	O	710	714	vivo	vivo	I-ADVP	FW	O	29	NMOD	O
O	O	715	717	to	to	B-PP	TO	O	29	NMOD	O
O	O	718	726	alveolar	alveolar	B-NP	JJ	B-cell_type	34	NMOD	B-cell_type
O	O	727	738	macrophages	macrophage	I-NP	NNS	I-cell_type	32	PMOD	I-cell_type
O	O	739	740	(	(	O	(	O	37	DEP	O
O	O	740	743	AMs	AM	B-NP	NNS	B-cell_type	37	DEP	B-cell_type
O	O	743	744	)	)	O	)	O	34	NMOD	O
O	O	744	745	.	.	O	.	O	2	P	O

O	O	746	753	Freshly	Freshly	B-NP	RB	O	3	NMOD	O
O	O	754	762	isolated	isolate	I-NP	VBN	O	3	NMOD	O
O	O	763	772	monocytes	monocyte	I-NP	NNS	B-cell_type	5	SUB	B-cell_type
O	O	773	787	constitutively	constitutively	B-ADVP	RB	O	5	VMOD	O
O	O	788	797	expressed	express	B-VP	VBD	O	0	ROOT	O
O	O	798	802	high	high	B-NP	JJ	O	7	NMOD	O
O	O	803	809	levels	level	I-NP	NNS	O	5	OBJ	O
O	O	810	812	of	of	B-PP	IN	O	7	NMOD	O
O	O	813	830	transcriptionally	transcriptionally	B-NP	RB	B-protein	12	NMOD	B-protein
O	O	831	839	inactive	inactive	I-NP	JJ	I-protein	12	NMOD	I-protein
T2	B-Protein	840	843	p50	p50	I-NP	NN	I-protein	12	NMOD	I-protein
T17	B-Entity	844	853	homodimer	homodimer	I-NP	NN	I-protein	8	PMOD	I-protein
O	O	854	859	which	which	B-NP	WDT	O	7	NMOD	O
O	O	860	869	decreased	decrease	B-VP	VBD	O	13	SBAR	O
O	O	870	874	with	with	B-PP	IN	O	14	VMOD	O
O	O	875	879	time	time	B-NP	NN	O	15	PMOD	O
O	O	880	882	in	in	B-PP	IN	O	14	VMOD	O
O	O	883	890	culture	culture	B-NP	NN	O	17	PMOD	O
O	O	891	893	in	in	B-PP	IN	O	14	VMOD	O
O	O	894	899	favor	favor	B-NP	NN	O	19	PMOD	O
O	O	900	902	of	of	B-PP	IN	O	20	NMOD	O
O	O	903	906	the	the	B-NP	DT	O	32	NMOD	O
O	O	907	924	transcriptionally	transcriptionally	I-NP	RB	O	24	AMOD	O
O	O	925	931	active	active	I-NP	JJ	O	32	NMOD	O
T3	B-Protein	932	935	p50	p50	I-NP	NN	B-protein	32	NMOD	B-protein
O	O	935	936	/	/	B-NP	SYM	O	32	P	O
T4	B-Protein	936	939	p65	p65	B-NP	NN	B-protein	32	NMOD	B-protein
O	O	940	943	and	and	O	CC	O	32	NMOD	O
T5	B-Protein	944	947	p50	p50	B-NP	NN	B-protein	32	NMOD	B-protein
O	O	947	948	/	/	O	SYM	O	32	P	O
T6	B-Protein	948	952	RelB	RelB	B-NP	NN	B-protein	32	NMOD	B-protein
T18	B-Entity	953	965	heterodimers	heterodimer	I-NP	NNS	I-protein	21	PMOD	I-protein
O	O	965	966	.	.	O	.	O	5	P	O

O	O	967	969	As	As	B-PP	IN	O	7	VMOD	O
O	O	970	972	in	in	B-PP	IN	O	1	PMOD	O
O	O	973	977	MDMs	MDM	B-NP	NNS	B-cell_type	2	PMOD	B-cell_type
O	O	977	978	,	,	O	,	O	7	P	O
O	O	979	982	AMs	AM	B-NP	NNS	B-cell_type	7	SUB	B-cell_type
O	O	983	997	constitutively	constitutively	B-ADVP	RB	O	7	VMOD	O
O	O	998	1007	expressed	express	B-VP	VBD	O	0	ROOT	O
T7,T19	B-Protein,B-Entity	1008	1011	p50	p50	B-NP	NN	B-protein	12	NMOD	B-protein
T19	I-Entity	1011	1012	/	/	O	SYM	O	12	P	O
T8,T19	B-Protein,I-Entity	1012	1015	p65	p65	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	1016	1019	and	and	O	CC	O	12	NMOD	O
T9,T20	B-Protein,B-Entity	1020	1023	p50	p50	B-NP	NN	B-protein	14	NMOD	B-protein
T20	I-Entity	1023	1024	/	/	O	SYM	O	14	P	O
T10,T20	B-Protein,I-Entity	1024	1028	RelB	RelB	B-NP	NN	B-protein	7	OBJ	B-protein
O	O	1029	1037	although	although	B-SBAR	IN	O	7	VMOD	O
O	O	1038	1040	at	at	B-PP	IN	O	15	DEP	O
O	O	1041	1046	lower	low	B-NP	JJR	O	18	NMOD	O
O	O	1047	1053	levels	level	I-NP	NNS	O	16	PMOD	O
O	O	1053	1054	.	.	O	.	O	7	P	O

O	O	1055	1058	HIV	HIV	B-NP	NN	O	2	NMOD	O
O	O	1059	1068	infection	infection	I-NP	NN	O	6	SUB	O
O	O	1069	1071	of	of	B-PP	IN	O	2	NMOD	O
O	O	1072	1077	fresh	fresh	B-NP	JJ	O	3	PMOD	O
O	O	1078	1087	monocytes	monocyte	I-NP	NNS	B-cell_type	4	NMOD	B-cell_type
O	O	1088	1094	failed	fail	B-VP	VBD	O	0	ROOT	O
O	O	1095	1097	to	to	I-VP	TO	O	8	VMOD	O
O	O	1098	1104	induce	induce	I-VP	VB	O	6	VMOD	O
T11,T21	B-Protein,B-Entity	1105	1108	p50	p50	B-NP	NN	B-protein	11	NMOD	B-protein
T21	I-Entity	1108	1109	/	/	O	SYM	O	11	P	O
T12,T21	B-Protein,I-Entity	1109	1112	p65	p65	B-NP	NN	B-protein	8	OBJ	B-protein
O	O	1113	1115	as	as	B-SBAR	IN	O	8	VMOD	O
O	O	1116	1120	seen	see	B-VP	VBN	O	12	SBAR	O
O	O	1121	1123	in	in	B-PP	IN	O	13	VMOD	O
O	O	1124	1128	MDMs	MDM	B-NP	NNS	B-cell_type	14	PMOD	B-cell_type
O	O	1128	1129	.	.	O	.	O	6	P	O

O	O	1130	1133	The	The	B-NP	DT	O	2	NMOD	O
O	O	1134	1145	replacement	replacement	I-NP	NN	O	14	SUB	O
O	O	1146	1148	of	of	B-PP	IN	O	2	NMOD	O
T13	B-Protein	1149	1152	p50	p50	B-NP	NN	B-protein	5	NMOD	B-protein
T22	B-Entity	1153	1163	homodimers	homodimer	I-NP	NNS	I-protein	3	PMOD	I-protein
O	O	1164	1168	with	with	B-PP	IN	O	2	NMOD	O
T23	B-Entity	1169	1186	transcriptionally	transcriptionally	B-NP	RB	O	8	AMOD	O
T23	I-Entity	1187	1193	active	active	I-NP	JJ	O	9	NMOD	O
T23	I-Entity	1194	1206	heterodimers	heterodimer	I-NP	NNS	O	6	PMOD	O
O	O	1207	1216	following	follow	B-PP	VBG	O	2	NMOD	O
O	O	1217	1221	time	time	B-NP	NN	O	10	PMOD	O
O	O	1222	1224	in	in	B-PP	IN	O	11	NMOD	O
O	O	1225	1232	culture	culture	B-NP	NN	O	12	PMOD	O
O	O	1233	1236	may	may	B-VP	MD	O	0	ROOT	O
O	O	1237	1246	partially	partially	I-VP	RB	O	14	VMOD	O
O	O	1247	1254	explain	explain	I-VP	VB	O	14	VC	O
O	O	1255	1258	the	the	B-NP	DT	O	19	NMOD	O
O	O	1259	1270	progressive	progressive	I-NP	JJ	O	19	NMOD	O
O	O	1271	1279	increase	increase	I-NP	NN	O	16	OBJ	O
O	O	1280	1282	in	in	B-PP	IN	O	19	NMOD	O
O	O	1283	1297	susceptibility	susceptibility	B-NP	NN	O	20	PMOD	O
O	O	1298	1300	of	of	B-PP	IN	O	21	NMOD	O
O	O	1301	1310	monocytes	monocyte	B-NP	NNS	B-cell_type	22	PMOD	B-cell_type
O	O	1311	1313	to	to	B-PP	TO	O	21	NMOD	O
O	O	1314	1317	HIV	HIV	B-NP	NN	O	26	NMOD	O
O	O	1318	1327	infection	infection	I-NP	NN	O	24	PMOD	O
O	O	1328	1334	during	during	B-PP	IN	O	19	NMOD	O
O	O	1335	1337	in	in	B-NP	FW	O	29	AMOD	O
O	O	1338	1343	vitro	vitro	I-NP	FW	O	30	NMOD	O
O	O	1344	1351	culture	culture	I-NP	NN	O	27	PMOD	O
O	O	1351	1352	.	.	O	.	O	14	P	O

O	O	1353	1356	The	The	B-NP	DT	O	2	NMOD	O
O	O	1357	1363	change	change	I-NP	NN	O	13	SUB	O
O	O	1364	1366	in	in	B-PP	IN	O	2	NMOD	O
T24	B-Entity	1367	1369	NF	NF	B-NP	NN	B-protein	7	NMOD	B-protein
T24	I-Entity	1369	1370	-	-	B-NP	HYPH	I-protein	7	NMOD	I-protein
T24	I-Entity	1370	1376	kappaB	kappaB	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	1377	1387	components	component	I-NP	NNS	I-protein	3	PMOD	I-protein
O	O	1388	1392	with	with	B-PP	IN	O	2	NMOD	O
O	O	1393	1401	monocyte	monocyte	B-NP	NN	O	10	NMOD	O
O	O	1402	1417	differentiation	differentiation	I-NP	NN	O	8	PMOD	O
O	O	1418	1420	in	in	B-ADVP	FW	O	12	AMOD	O
O	O	1421	1425	vivo	vivo	I-ADVP	FW	O	10	NMOD	O
O	O	1426	1429	may	may	B-VP	MD	O	0	ROOT	O
O	O	1430	1434	also	also	I-VP	RB	O	13	VMOD	O
O	O	1435	1442	explain	explain	I-VP	VB	O	13	VC	O
O	O	1443	1446	the	the	B-NP	DT	O	19	NMOD	O
O	O	1447	1456	different	different	I-NP	JJ	O	18	AMOD	O
O	O	1457	1472	transcriptional	transcriptional	I-NP	JJ	O	19	NMOD	O
O	O	1473	1483	activities	activity	I-NP	NNS	O	15	OBJ	O
O	O	1484	1486	of	of	B-PP	IN	O	19	NMOD	O
O	O	1487	1492	these	these	B-NP	DT	O	23	NMOD	O
O	O	1493	1497	cell	cell	I-NP	NN	O	23	NMOD	O
O	O	1498	1509	populations	population	I-NP	NNS	O	20	PMOD	O
O	O	1510	1512	in	in	B-PP	IN	O	19	NMOD	O
O	O	1513	1516	HIV	HIV	B-NP	NN	O	28	NMOD	O
O	O	1516	1517	-	-	B-NP	HYPH	O	28	NMOD	O
O	O	1517	1525	infected	infect	I-NP	VBN	O	28	NMOD	O
O	O	1526	1537	individuals	individual	I-NP	NNS	O	24	PMOD	O
O	O	1537	1538	.	.	O	.	O	13	P	O
